Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans.
about
Nutritional therapy in autosomal dominant polycystic kidney disease.Cystic Kidney Diseases From the Adult Nephrologist's Point of View.Activation of the Calcium-Sensing Receptor Corrects the Impaired Mitochondrial Energy Status Observed in Renal Polycystin-1 Knockdown Cells Modeling Autosomal Dominant Polycystic Kidney Disease
P2860
Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Defective glycolysis and the u ...... from animal models to humans.
@en
Defective glycolysis and the u ...... from animal models to humans.
@nl
type
label
Defective glycolysis and the u ...... from animal models to humans.
@en
Defective glycolysis and the u ...... from animal models to humans.
@nl
prefLabel
Defective glycolysis and the u ...... from animal models to humans.
@en
Defective glycolysis and the u ...... from animal models to humans.
@nl
P2860
P1476
Defective glycolysis and the u ...... : from animal models to humans
@en
P2093
Alessandra Boletta
Riccardo Magistroni
P2860
P2888
P304
P356
10.1007/S40620-017-0395-9
P577
2017-04-07T00:00:00Z